Bay Street News, March, 2024

SCOTTSDALE, Ariz., March 14, 2024 (GLOBE NEWSWIRE) — AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”) the owner of GunBroker.com, […]

– Company aligned with FDA on requirements for ongoing Phase 2 AQUAx2 clinical trial for Grade 2/3 radiation-induced xerostomia to […]

SAN DIEGO, March 14, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), renowned […]

DURHAM, N.C., March 14, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing […]

ST. LOUIS, March 14, 2024 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced it has signed a definitive […]

ROSELAND, N.J., March 14, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments […]

Vancouver, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; […]

PALO ALTO, Calif., March 14, 2024 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the […]

First trial to ever evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer […]

CERRITOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: TOI), a leading value-based oncology group, and […]